Current Grant Opportunity View - GO6431

This is for Stream 4 Stage 2 applicants only.

The objective of this grant opportunity is to:

• Stream 4:
  • Stage 2 (Targeted Call for Research): establish a multidisciplinary national adaptive platform trial that accelerates assessment and implementation of therapeutic interventions (pharmacological and non-pharmacological) for PASC.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.

Further information on the Medical Research Future Fund is available from the Department of Health and Aged Care’s website.

Applications will only be accepted from approved MRFF Eligible Organisations. A list of approved MRFF Eligible Organisations is available from the GrantConnect GO Documents and from the MRFF Eligible Organisations List on the NHMRC website.

Applications must satisfy all the requirements set out in the Medical Research Future Fund – EPCDRI – 2023 Post-Acute Sequelae of COVID-19 Grant Opportunity Guidelines.

The maximum grant duration is:

• Stream 4 Stage 2: 5 years

$8,000,000.00

From $0.00 to $8,000,000.00

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the MRFF Eligible Organisation that will submit the application to identify any specific requirements that the Organisation might have.

Applications must be submitted electronically using NHMRC’s online granting system (Sapphire).

Questions should be submitted no later than 1:00pm (ACT Local Time) on 23 April 2025.